Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
July 16, 2025 Off

Aptose Receives Second Advance under the Loan Agreement with Hanmi Pharmaceutical to Continue Development of Tuspetinib in Triplet Therapy for AML

By GlobeNewswire

SAN DIEGO and TORONTO, July 15, 2025 (GLOBE NEWSWIRE) — Aptose Biosciences Inc. (“Aptose” or the “Company”) (TSX: APS; OTC:…

July 15, 2025 Off

Aquablation® Therapy’s Assigned Category I Code in 2026 Medicare Proposed Physician Fee Schedule

By GlobeNewswire

SAN JOSE, Calif., July 14, 2025 (GLOBE NEWSWIRE) — PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company…

July 15, 2025 Off

Kane Biotech to Present at Advanced Wound Care Summit USA

By GlobeNewswire

WINNIPEG, Manitoba, July 14, 2025 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX-V: KNE) (“Kane Biotech” or “Kane”) announces today that…

July 15, 2025 Off

Longevity Health Holdings Announces Merger with THPlasma and Termination of 20/20 BioLabs Transaction

By GlobeNewswire

PITTSBURGH, July 14, 2025 (GLOBE NEWSWIRE) — Longevity Health Holdings, Inc. (Nasdaq: XAGE), a company focused on human longevity and…

July 15, 2025 Off

Sanara MedTech Inc. Announces Launch of Tissue Health Plus Wound Care Provider Pilot Program

By GlobeNewswire

Pilot program designed to provide real-world evidence in the use of Tissue Health Plus’ technology platform FORT WORTH, TX, July…

July 15, 2025 Off

Alumis Announces the Promotion of Sanam Pangali to Chief Legal Officer and Corporate Secretary

By GlobeNewswire

SOUTH SAN FRANCISCO, Calif., July 14, 2025 (GLOBE NEWSWIRE) — Alumis Inc. (Nasdaq: ALMS), a late-stage biopharma company developing next-generation…

July 15, 2025 Off

Hyperion DeFi Adds $5 Million in HYPE to its Treasury Holdings

By GlobeNewswire

Increases total holdings to 1,427,178 HYPELAGUNA HILLS, Calif., July 14, 2025 (GLOBE NEWSWIRE) — Hyperion DeFi, Inc. (NASDAQ: HYPD) (“Hyperion…

July 15, 2025 Off

60 Degrees Pharmaceuticals to Submit MUMS (Minor Use/Minor Species) Designation Request to FDA for Tafenoquine for Acute Canine Babesiosis in 2025

By GlobeNewswire

Data from three independent clinical studies demonstrate utility of tafenoquine to treat acute canine babesiosis WASHINGTON, July 14, 2025 (GLOBE…

July 15, 2025 Off

New 3-Year Phase 3 Data Confirmed Sustained Response to TransCon® PTH (Palopegteriparatide) Therapy in Adults with Hypoparathyroidism, Including Improvements in Biochemistries, Kidney Function, and Quality of Life

By GlobeNewswire

COPENHAGEN, Denmark, July 14, 2025 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND) today announced new data from Week 156…

July 15, 2025 Off

Branded Legacy Inc. Announces Leadership Transition and Pending Merger with Innovative Addiction Therapeutics Company Projecting $40 Million in First-Year Revenue

By GlobeNewswire

ORLANDO, Fla., July 14, 2025 (GLOBE NEWSWIRE) — via IBN — Branded Legacy Inc. (OTC: BLEG), a diversified holdings company,…

Posts pagination

Previous 1 … 123 124 125 … 3,605 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine